VIRX News and Press, Viracta Therapeutics Inc. From 08/11/22

Viracta Therapeutics Appoints Jane Chung, R.Ph., to its Board of Directors PR Newswire SAN DIEGO , Aug. 11, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. ( Nasdaq : VIRX ), a precision oncology company targeting virus-associated malignanci...

Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates PR Newswire Continued progress of NAVAL-1, the pivotal trial of Nana-val for the treatment of Epstein-Barr virus-positive (EBV + ) lymphoma; update on the initial cohort(s) expand...

Gainers: SIGA Technologies SIGA +20% . Tonix Pharmaceuticals TNXP +16% . Chimerix CMRX +13% . Galectin Therapeutics ( GALT ) +7% . Verona Pharma ( VRNA ) +3% . Losers: Enveric Biosciences ( ENVB ) -23% . Koninkli...

Viracta Therapeutics President and Chief Executive Officer Dr. Ivor Royston Receives the Science History Institute's Biotechnology Heritage Award PR Newswire SAN DIEGO , June 13, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precis...

The following slide deck was published by Viracta Therapeutics, Inc. in conjunction with this event. For further details see: Viracta Therapeutics (VIRX) Investor Presentation - Slideshow

Gainers: Power bridge Technologies (PBTS) +177%. Applied UV (AUVI) +50%. Cardiff Oncology (CRDF) +38%. DBV Technologies (DBVT) +28%. View (VIEW) +24%. Viracta Therapeutics (VIRX) +22%. Finger Motion (FNGR) +21%. Scien joy (SJ) +20%. Aero Clean Technologies (AERC) +19%. Akso Health Group (AHG)...

Gainers: DBV Technologies (DBVT) +21%. Rubius Therapeutics (RUBY) +20%. Annovis Bio (ANVS) +17%. LumiraDx (LMDX) +16%. CTI BioPharma (CTIC) +15%. Losers: Rigel Pharmaceuticals (RIGL) -48%. Cosmos (COSM) -13%. Accelerate Diagnostics (AXDX) ...

Viracta Therapeutics Provides an Update on the Phase 1b/2 Trial of Nana-val in Patients with Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors and Announces Upcoming Poster Presentation at the ASCO Annual Meeting PR Newswire Trial has advanced to the second dose...

Viracta Therapeutics to Present at the Jefferies Healthcare Conference PR Newswire SAN DIEGO , June 1, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announce...

SQZ Biotechnologies (NYSE:SQZ) has appointed Marshelle Smith Warren as chief medical officer, effective June 1. She was previously CMO and SVP, R&D at Viracta Therapeutics (VIRX). She has also served as a senior advisor clinical research programs for investigational T cell therapies ...